Trials / Conditions / Idiopathic Gastroparesis

Idiopathic Gastroparesis

15 registered clinical trials studyying Idiopathic Gastroparesis — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Active Not Recruiting	A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adult Subjects With Idiopathic Gast NCT06899217	CinDome Pharma, Inc.	Phase 2
Recruiting	Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis NCT06836557	Vanda Pharmaceuticals	Phase 3
Completed	A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants With Symptomatic Diabetic or Idiopa NCT04303195	Neurogastrx, Inc.	Phase 2
Completed	Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis NCT04028492	Vanda Pharmaceuticals	Phase 3
Completed	Gastroparesis Registry 3 NCT03680859	Johns Hopkins Bloomberg School of Public Health	—
Completed	A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Di NCT03544229	Millennium Pharmaceuticals, Inc.	Phase 2
Completed	Effect of TAK-954 on Gastrointestinal and Colonic Transit in Diabetic or Idiopathic Gastroparesis Participants NCT03281577	Takeda	Phase 2
Completed	G-POEM for Treatment of Refractory Gastroparesis NCT02732821	Johns Hopkins University	—
Unknown	Effects of Global Osteopathic Manual Treatments in Patients With Idiopathic Gastroparesis NCT02232334	Kathleen Brannan Brown, Inc.	N/A
Completed	Intraluminal Endosonography for Examination of the Structural Changes of the Stomach in Gastroparetic Patients NCT01916460	Texas Tech University Health Sciences Center, El Paso	N/A
Terminated	A Pilot Study on the Efficacy and Safety of Olanzapine in Gastroparesis NCT01625923	University of Michigan	N/A
Completed	Biomagnetic Characterization of Gastric Dysrhythmias III NCT03176927	Vanderbilt University Medical Center	EARLY_Phase 1
Completed	Gastroparesis Registry 2 NCT01696747	Johns Hopkins Bloomberg School of Public Health	—
Recruiting	Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168	Sanford Health	—
Completed	Nortriptyline for Idiopathic Gastroparesis NCT00765895	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Phase 3